Exome Asset Management’s Guardant Health GH Stock Holding History

Exome Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.1M	Sell	67,500 -15,236	-18%	-$1.66M	6.25%	1
2026 Q1	$7.64M	Sell	82,736 -15,446	-16%	-$1.55M	3.95%	6
2025 Q4	$10M	Hold	98,182	–	–	4.79%	3
2025 Q3	$6.13M	Hold	98,182	–	–	3.71%	5
2025 Q2	$5.11M	Sell	98,182 -29,000	-23%	-$1.3M	3.8%	3
2025 Q1	$5.42M	Sell	127,182 -20,618	-14%	-$890K	4.82%	2
2024 Q4	$4.52M	Buy	147,800 +58,000	+65%	+$1.63M	3.39%	5
2024 Q3	$2.06M	Buy	89,800 +10,800	+14%	+$306K	1.39%	34
2024 Q2	$2.28M	Hold	79,000	–	–	2.03%	23
2024 Q1	$1.63M	Buy	+79,000	New	+$1.69M	1.4%	32

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Exome Asset Management's GH Position: Q2 2026 in Review

Exome Asset Management reduced its Guardant Health (GH) stake by 18% in Q2 2026, selling an estimated $1.66M and leaving 67,500 shares worth $10.1M. The position accounts for 6.25% of the portfolio, ranked #1.

Exome Asset Management first reported a position in GH in Q1 2024 and has held it in 10 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Exome Asset Management held 67,500 shares of Guardant Health worth $10.1M as of Q2 2026.
Exome Asset Management sold 15,236 Guardant Health shares in Q2 2026, an estimated $1.66M.
Guardant Health made up 6.25% of Exome Asset Management's portfolio in Q2 2026, its #1 holding.
Exome Asset Management first reported a position in Guardant Health in Q1 2024 and has held it in 10 quarters since.
598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.